A novel oxiranylchromenone derivative, MHY336, induces apoptosis and cell cycle arrest via a p53- and p21-dependent pathway in HCT116 human colon cancer cells

International Journal of Oncology
Sun Hwa LeeNam Deuk Kim

Abstract

In this study, we compared cytotoxicity, cell cycle distribution, and apoptosis on MHY336 treatment in three human colorectal carcinoma HCT116 cells: p53+/+ (p53‑wt), p53-/- (p53-null), and p21-/- (p21-null), as well as investigated the roles of p53 and p21 in cell death. Using these three isogenic variants, the roles of p53 and p21 in the cellular response to treatment with MHY336, a novel topoisomerase IIα inhibitor, were investigated. Our results showed that MHY336 treatment increased the expression of p53 over time in cells with wild-type p53 status. This elevated levels of p53 is associated with increased DNA fragmentation, and cleavage of poly(ADP-ribose) polymerase, consistent with increased sensitivity of these cells to apoptotic stimuli. However, p53-null and p21-null cells were more resistant to the antiproliferative and apoptotic effects of MHY336 than p53-wt cells. The same result was achieved by knocking down p53 and p21 with siRNA in p53-wt cells, indicating that p53 and p21 play a crucial role in MHY336-induced cell cycle arrest and apoptosis. Taken together, these results suggest that MHY336 could be a potential candidate to be used in chemoprevention and/or treatment of colon cancer.

References

Feb 1, 1995·Journal of Natural Products·A ConstantinouR Moon
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 16, 1993·Nature·Y XiongD Beach
Nov 15, 1996·Nucleic Acids Research·M I SandriF Vikhanskaya
Jan 1, 1997·Molecular and Cellular Biology·Q WangD P Suttle
Jan 1, 1997·Free Radical Biology & Medicine·G CaoR L Prior
Nov 20, 1997·Journal of Cellular Physiology·X W Wang, C C Harris
Feb 2, 1999·Experimental Cell Research·A L Gartel, A L Tyner
Mar 9, 2002·Molecular and Cellular Biology·Sudesh AgrawalGuy M Chisolm
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Mar 26, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Nikola I Valkov, Daniel M Sullivan
Jul 26, 2003·The EMBO Journal·Fabienne BausVjekoslav Dulić
Sep 16, 2003·Journal of Cell Science·Susan HauptYgal Haupt
Aug 20, 2004·The Biochemical Journal·Marcus E Peter
Jun 11, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lisa Oliver, François M Vallette
Nov 24, 2007·Critical Reviews in Oncology/hematology·Gioacchin IannoloRuggero De Maria
May 23, 2008·Cytokine & Growth Factor Reviews·Avi Ashkenazi
Apr 14, 2009·Trends in Molecular Medicine·Shi Yu YangMarc C Winslet
Mar 23, 2010·Lancet·David CunninghamNaureen Starling
Apr 25, 2013·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyu-Won JungJin-Soo Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis